{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:27:16Z","timestamp":1779110836814,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiaxing Key Discipline of Medicine-Nephrology","award":["2023-ZC-011"],"award-info":[{"award-number":["2023-ZC-011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04599-x","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:46:27Z","timestamp":1765536387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Renal gelsolin amyloidosis as a rare cause of proteinuria: a case report and literature review"],"prefix":"10.1186","volume":"26","author":[{"given":"Miner","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingyuan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henglan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"3","key":"4599_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/10409238.2012.661401","volume":"47","author":"JP Solomon","year":"2012","unstructured":"Solomon JP, Page LJ, Balch WE, et al. Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention. Crit Rev Biochem Mol Biol. 2012;47(3):282\u201396.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"5732","key":"4599_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/281583a0","volume":"281","author":"HL Yin","year":"1979","unstructured":"Yin HL, Stossel TP. Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein. Nature. 1979;281(5732):583\u20136.","journal-title":"Nature"},{"issue":"6087","key":"4599_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/323455a0","volume":"323","author":"DJ Kwiatkowski","year":"1986","unstructured":"Kwiatkowski DJ, Stossel TP, Orkin SH, et al. Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature. 1986;323(6087):455\u20138.","journal-title":"Nature"},{"issue":"2","key":"4599_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/ng1092-157","volume":"2","author":"A Delachapelle","year":"1992","unstructured":"Delachapelle A, Tolvanen R, Boysen G, et al. Gelsolin-derived Familial amyloidosis caused by asparagine or tyrosine substitution for aspartic-acid at residue 187. Nat Genet. 1992;2(2):157\u201360.","journal-title":"Nat Genet"},{"issue":"2","key":"4599_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nsb745","volume":"9","author":"SL Kazmirski","year":"2002","unstructured":"Kazmirski SL, Isaacson RL, An C, et al. Loss of a metal-binding site in Gelsolin leads to Familial amyloidosis-Finnish type. Nat Struct Biol. 2002;9(2):112\u20136.","journal-title":"Nat Struct Biol"},{"issue":"1","key":"4599_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jmb.2003.09.029","volume":"334","author":"ME Huff","year":"2003","unstructured":"Huff ME, Page LJ, Balch WE, et al. Gelsolin domain 2 Ca2\u2009+\u2009affinity determines susceptibility to Furin proteolysis and Familial amyloidosis of Finnish type. J Mol Biol. 2003;334(1):119\u201327.","journal-title":"J Mol Biol"},{"issue":"48","key":"4599_CR7","doi-asserted-by":"publisher","first-page":"11370","DOI":"10.1021\/bi901368e","volume":"48","author":"JP Solomon","year":"2009","unstructured":"Solomon JP, Yonemoto IT, Murray AN, et al. The 8 and 5\u00a0kDa fragments of plasma Gelsolin form amyloid fibrils by a nucleated polymerization mechanism, while the 68\u00a0kDa fragment is not amyloidogenic. Biochemistry. 2009;48(48):11370\u201380.","journal-title":"Biochemistry"},{"issue":"4","key":"4599_CR8","first-page":"314","volume":"1","author":"J Meretoja","year":"1969","unstructured":"Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res. 1969;1(4):314\u201324.","journal-title":"Ann Clin Res"},{"issue":"1","key":"4599_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/13506129809007291","volume":"5","author":"S Kiuru","year":"1998","unstructured":"Kiuru S. Gelsolin-related Familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid. 1998;5(1):55\u201366.","journal-title":"Amyloid"},{"issue":"4","key":"4599_CR10","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.kint.2016.11.017","volume":"91","author":"S Sethi","year":"2017","unstructured":"Sethi S, Dasari S, Amin MS, et al. Clinical, biopsy, and mass spectrometry findings of renal Gelsolin amyloidosis. Kidney Int. 2017;91(4):964\u201371.","journal-title":"Kidney Int"},{"issue":"1","key":"4599_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13023-020-1300-5","volume":"15","author":"EK Schmidt","year":"2020","unstructured":"Schmidt EK, Mustonen T, Kiuru-Enari S, et al. Finnish Gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study. Orphanet J Rare Dis. 2020;15(1):19.","journal-title":"Orphanet J Rare Dis"},{"key":"4599_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/B978-0-444-52902-2.00039-4","volume":"115","author":"S Kiuru-Enari","year":"2013","unstructured":"Kiuru-Enari S, Haltia M. Hereditary Gelsolin amyloidosis. Handb Clin Neurol. 2013;115:659\u201381.","journal-title":"Handb Clin Neurol"},{"issue":"6","key":"4599_CR13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/07853890.2015.1075063","volume":"47","author":"T Nikoskinen","year":"2015","unstructured":"Nikoskinen T, Schmidt EK, Strbian D, et al. Natural course of Finnish Gelsolin amyloidosis. Ann Med. 2015;47(6):506\u201311.","journal-title":"Ann Med"},{"issue":"3","key":"4599_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1399-0004.1973.tb01140.x","volume":"4","author":"J Meretoja","year":"1973","unstructured":"Meretoja J. Genetic aspects of Familial amyloidosis with corneal lattice dystrophy and cranial neuropathy. Clin Genet. 1973;4(3):173\u201385.","journal-title":"Clin Genet"},{"issue":"8","key":"4599_CR15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1755-3768.2009.01686.x","volume":"87","author":"C Carrwik","year":"2009","unstructured":"Carrwik C, Stenevi U. Lattice corneal dystrophy, Gelsolin type (Meretoja\u2019s syndrome). Acta Ophthalmol. 2009;87(8):813\u20139.","journal-title":"Acta Ophthalmol"},{"key":"4599_CR16","doi-asserted-by":"crossref","unstructured":"Minnella AM, Rissotto R, Antoniazzi E, et al. Ocular involv hereditary amyloidosis. Genes. 2021;12(7).","DOI":"10.3390\/genes12070955"},{"issue":"1","key":"4599_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/ndt\/gfl548","volume":"22","author":"MR Ardalan","year":"2007","unstructured":"Ardalan MR, Shoja MM, Kiuru-Enari S. Amyloidosis-related nephrotic syndrome due to a G654A Gelsolin mutation: the first report from the middle East. Nephrol Dialysis Transplantation. 2007;22(1):272\u20135.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"1","key":"4599_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/13506120601116393","volume":"14","author":"M Tanskanen","year":"2007","unstructured":"Tanskanen M, Paetau A, Salonen O, et al. Severe ataxia with neuropathy in hereditary Gelsolin amyloidosis: a case report. Amyloid. 2007;14(1):89\u201395.","journal-title":"Amyloid"},{"issue":"1","key":"4599_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0022-510X(94)90092-2","volume":"126","author":"S Kiuru","year":"1994","unstructured":"Kiuru S, Matikainen E, Kupari M, et al. Autonomic nervous-system and cardiac involvement in Familial amyloidosis, Finnish type (FAF). J Neurol Sci. 1994;126(1):40\u20138.","journal-title":"J Neurol Sci"},{"issue":"5","key":"4599_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1179\/174313209X409007","volume":"32","author":"K Makioka","year":"2010","unstructured":"Makioka K, Ikeda M, Ikeda Y, et al. Familial amyloid polyneuropathy (Finnish type) presenting multiple cranial nerve deficits with carpal tunnel syndrome and orthostatic hypotension. Neurol Res. 2010;32(5):472\u20135.","journal-title":"Neurol Res"},{"issue":"2","key":"4599_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1365-2133.2004.06276.x","volume":"152","author":"S Kiuru-Enari","year":"2005","unstructured":"Kiuru-Enari S, Keski-Oja J, Haltia M. Cutis Laxa in hereditary Gelsolin amyloidosis. Br J Dermatol. 2005;152(2):250\u20137.","journal-title":"Br J Dermatol"},{"issue":"3","key":"4599_CR22","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/0888-7543(92)90183-S","volume":"13","author":"CPJ Maury","year":"1992","unstructured":"Maury CPJ, Kere J, Tolvanen R, et al. Homozygosity for the Asn187 Gelsolin mutation in Finnish-Type Familial amyloidosis is associated with severe Renal-Disease. Genomics. 1992;13(3):902\u20133.","journal-title":"Genomics"},{"issue":"4","key":"4599_CR23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/jclinpath-2014-202722","volume":"68","author":"JA Gilbertson","year":"2015","unstructured":"Gilbertson JA, Theis JD, Vrana JA, et al. A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue. J Clin Pathol. 2015;68(4):314\u20137.","journal-title":"J Clin Pathol"},{"issue":"3","key":"4599_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/13506129.2021.1911798","volume":"28","author":"T Mustonen","year":"2021","unstructured":"Mustonen T, Holkeri A, Holmstr\u00f6m M, et al. Cardiac manifestations in Finnish Gelsolin amyloidosis patients. Amyloid. 2021;28(3):168\u201372.","journal-title":"Amyloid"},{"issue":"6","key":"4599_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/14017439709075953","volume":"31","author":"AL Fern\u00e1ndez","year":"1997","unstructured":"Fern\u00e1ndez AL, Herreros JM, Monzonis AM, et al. Heart transplantation for Finnish type Familial systemic amyloidosis. Scandinavian Cardiovasc J. 1997;31(6):357\u20139.","journal-title":"Scandinavian Cardiovasc J"},{"issue":"1","key":"4599_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/13506129.2024.2441784","volume":"32","author":"A Rold\u00e1n-Sevilla","year":"2025","unstructured":"Rold\u00e1n-Sevilla A, Gallego-Delgado M, Lista-Araujo MT, et al. Clinical and genetic features of agel amyloidosis caused by novel Gelsolin variant and its impact on cardiac function and conduction disorders. Amyloid. 2025;32(1):90\u20132.","journal-title":"Amyloid"},{"issue":"11","key":"4599_CR27","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s10067-009-1260-6","volume":"28","author":"P Juusela","year":"2009","unstructured":"Juusela P, Tanskanen M, Nieminen A, et al. Hereditary Gelsolin amyloidosis mimicking Sj\u00f6gren\u2019s syndrome. Clin Rheumatol. 2009;28(11):1351\u20134.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"4599_CR28","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s13760-024-02607-9","volume":"124","author":"G Mak","year":"2024","unstructured":"Mak G, Tarnopolsky M, Lu JQ. A case of mixed hereditary Gelsolin amyloidosis and hydroxychloroquine induced myopathy. Acta Neurol Belg. 2024;124(6):2099\u2013101.","journal-title":"Acta Neurol Belg"},{"issue":"2","key":"4599_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3109\/13506129.2014.891502","volume":"21","author":"YA Efebera","year":"2014","unstructured":"Efebera YA, Sturm A, Baack EC, et al. Novel Gelsolin variant as the cause of nephrotic syndrome and renal amyloidosis in a large kindred. Amyloid. 2014;21(2):110\u20132.","journal-title":"Amyloid"},{"issue":"5","key":"4599_CR30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/07853890.2016.1177197","volume":"48","author":"EK Schmidt","year":"2016","unstructured":"Schmidt EK, Atula S, Tanskanen M, et al. Causes of death and life span in Finnish Gelsolin amyloidosis. Ann Med. 2016;48(5):352\u20138.","journal-title":"Ann Med"},{"issue":"5","key":"4599_CR31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/MAJ.0b013e3181a4199c","volume":"337","author":"MM Shoja","year":"2009","unstructured":"Shoja MM, Ardalan MR, Tubbs RS, et al. Outcome of renal transplant in hereditary Gelsolin amyloidosis. Am J Med Sci. 2009;337(5):370\u20132.","journal-title":"Am J Med Sci"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04599-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04599-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04599-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:46:29Z","timestamp":1765536389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04599-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4599"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04599-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the ethics committee of The First Hospital of Jiaxing. All procedures in this study involving consent to participate were performed in accordance with the ethical standards of the institutional ethics and research committee. Written informed consent was obtained from the patient for participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication of this case report was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"692"}}